1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27186
Full metadata record
DC FieldValueLanguage
dc.contributor.authorda Silva, Ines Pires-
dc.contributor.authorAhmed, Tasnia-
dc.contributor.authorReijers, Irene L M-
dc.contributor.authorWarner, Allison Betof-
dc.contributor.authorPatrinely, James Randall-
dc.contributor.authorSerra-Bellver, Patricio-
dc.contributor.authorAllayous, Clara-
dc.contributor.authorMangana, Joanna-
dc.contributor.authorZimmer, Lisa-
dc.contributor.authorTrojaniello, Claudia-
dc.contributor.authorKlein, Oliver-
dc.contributor.authorGerard, Camille L-
dc.contributor.authorMichielin, Olivier-
dc.contributor.authorHaydon, Andrew-
dc.contributor.authorAscierto, Paolo A-
dc.contributor.authorCarlino, Matteo S-
dc.contributor.authorLebbe, Celeste-
dc.contributor.authorLorigan, Paul-
dc.contributor.authorJohnson, Douglas B-
dc.contributor.authorSandhu, Shahneen-
dc.contributor.authorLo, Serigne N-
dc.contributor.authorMenzies, Alexander M-
dc.contributor.authorLong, Georgina V-
dc.date.accessioned2021-08-09T05:49:26Z-
dc.date.available2021-08-09T05:49:26Z-
dc.date.issued2021-08-
dc.identifier.citationThe Lancet. Oncology 2021; 22(8): e343-e344en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27186-
dc.language.isoeng
dc.titleIpilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Oncologyen
dc.identifier.affiliationDivision of Cancer Services, The University of Manchester, Manchester, UKen
dc.identifier.affiliationCancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italyen
dc.identifier.affiliationMemorial Sloan Kettering Cancer Center, New York, NY, USAen
dc.identifier.affiliationVanderbilt University Medical Center, Nashville, TN, USAen
dc.identifier.affiliationDepartment of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germanyen
dc.identifier.affiliationThe Netherlands Cancer Institute, Amsterdam, Netherlandsen
dc.identifier.affiliationDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerlanden
dc.identifier.affiliationOncology Department, Lausanne University Hospital, Lausanne, Switzerlanden
dc.identifier.affiliationAP-HP Dermatology, INSERM U976, Université de Paris, Saint Louis Hospital, Paris, Franceen
dc.identifier.affiliationDepartment of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.affiliationMelanoma Institute Australia, University of Sydney, Sydney, NSW, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationDepartment of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, Melbourne, VIC, Australiaen
dc.identifier.doi10.1016/S1470-2045(21)00419-8en
dc.type.contentTexten
dc.identifier.pubmedid34339647
local.name.researcherKlein, Oliver
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptMedical Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.